1	Possible	Possible	B-NP	JJ	O	2	NMOD	0
2	role	role	I-NP	NN	O	0	ROOT	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	cyclooxygenase	cyclooxygenase	B-NP	NN	B-protein	3	PMOD	0
5	II	II	I-NP	CD	I-protein	4	NMOD	0
6	in	in	B-PP	IN	O	2	NMOD	0
7	the	the	B-NP	DT	O	8	NMOD	0
8	acquisition	acquisition	I-NP	NN	O	6	PMOD	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	ovarian	ovarian	B-NP	JJ	O	12	NMOD	0
11	luteal	luteal	I-NP	JJ	O	12	NMOD	0
12	function	function	I-NP	NN	O	9	PMOD	0
13	in	in	B-PP	IN	O	12	NMOD	0
14	rodents	rodent	B-NP	NNS	O	13	PMOD	0
15	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	development	development	I-NP	NN	O	15	SUB	2	development
3	of	of	B-PP	IN	O	2	NMOD	0
4	the	the	B-NP	DT	O	6	NMOD	0
5	corpus	corpus	I-NP	NN	O	6	NMOD	0
6	luteum	luteum	I-NP	NN	O	3	PMOD	0
7	(	(	O	(	O	9	DEP	0
8	CL	CL	B-NP	NN	O	9	DEP	0
9	)	)	O	)	O	6	NMOD	0
10	,	,	O	,	O	2	P	0
11	which	which	B-NP	WDT	O	2	NMOD	0
12	involves	involve	B-VP	VBZ	O	11	SBAR	0
13	angiogenesis	angiogenesis	B-NP	NN	O	12	OBJ	3	angiogenesis
14	,	,	O	,	O	2	P	0
15	is	be	B-VP	VBZ	O	0	ROOT	0
16	essential	essential	B-ADJP	JJ	O	15	PRD	0
17	for	for	B-PP	IN	O	16	AMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	establishment	establishment	I-NP	NN	O	17	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	early	early	B-NP	JJ	O	22	NMOD	0
22	pregnancy	pregnancy	I-NP	NN	O	20	PMOD	0
23	.	.	O	.	O	15	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	investigated	investigate	B-VP	VBD	O	0	ROOT	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	roles	role	I-NP	NNS	O	2	OBJ	16	roles
5	of	of	B-PP	IN	O	4	NMOD	0
6	the	the	B-NP	DT	O	8	NMOD	0
7	prostaglandin	prostaglandin	I-NP	NN	O	8	NMOD	0
8	synthases	synthas	I-NP	NNS	O	15	NMOD	0
9	cyclooxygenase	cyclooxygenase	I-NP	NN	B-protein	8	NMOD	0
10	(	(	O	(	O	12	DEP	0
11	COX	COX	B-NP	NN	B-protein	12	DEP	0
12	)	)	O	)	O	9	NMOD	0
13	I	I	B-NP	NN	O	15	NMOD	0
14	and	and	O	CC	O	15	NMOD	0
15	COX-II	COX-II	B-NP	NN	O	5	PMOD	0
16	in	in	B-PP	IN	O	4	NMOD	0
17	angiogenesis	angiogenesis	B-NP	NN	O	20	NMOD	3	angiogenesis
18	and	and	O	CC	O	20	NMOD	0
19	progesterone	progesterone	B-NP	NN	O	20	NMOD	0
20	production	production	I-NP	NN	O	16	PMOD	8	production
21	in	in	B-PP	IN	O	20	NMOD	0
22	the	the	B-NP	DT	O	25	NMOD	0
23	newly	newly	I-NP	RB	O	24	AMOD	0
24	formed	form	I-NP	VBN	O	25	NMOD	2	formed
25	CL	CL	I-NP	NN	O	21	PMOD	0
26	,	,	O	,	O	2	P	0
27	using	use	B-VP	VBG	O	2	VMOD	0
28	inhibitors	inhibitor	B-NP	NNS	O	27	OBJ	0
29	of	of	B-PP	IN	O	28	NMOD	0
30	the	the	B-NP	DT	O	32	NMOD	0
31	COX	COX	I-NP	NN	B-protein	32	NMOD	0
32	enzymes	enzyme	I-NP	NNS	I-protein	37	NMOD	0
33	and	and	O	CC	O	37	NMOD	0
34	the	the	B-NP	DT	O	37	NMOD	0
35	gonadotropin-induced	gonadotropin-induced	I-NP	JJ	O	37	NMOD	17	induced
36	pseudopregnant	pseudopregnant	I-NP	JJ	O	37	NMOD	19	pseudopregnant
37	rat	rat	I-NP	NN	O	29	PMOD	0
38	as	as	B-PP	IN	O	27	VMOD	0
39	a	a	B-NP	DT	O	40	NMOD	0
40	model	model	I-NP	NN	O	38	PMOD	0
41	.	.	O	.	O	2	P	0

1	Injection	Injection	B-NP	NN	O	18	NMOD	19	Injection
2	of	of	B-PP	IN	O	1	NMOD	0
3	indomethacin	indomethacin	B-NP	NN	O	8	NMOD	0
4	,	,	O	,	O	8	P	0
5	a	a	B-NP	DT	O	8	NMOD	0
6	nonselective	nonselective	I-NP	JJ	O	8	NMOD	0
7	COX	COX	I-NP	NN	O	8	NMOD	0
8	inhibitor	inhibitor	I-NP	NN	O	2	PMOD	0
9	,	,	O	,	O	1	P	0
10	on	on	B-PP	IN	O	1	NMOD	0
11	the	the	B-NP	DT	O	12	NMOD	0
12	day	day	I-NP	NN	O	10	PMOD	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	ovulation	ovulation	B-NP	NN	O	13	PMOD	0
15	and	and	O	CC	O	18	NMOD	0
16	the	the	B-NP	DT	O	18	NMOD	0
17	following	follow	I-NP	VBG	O	18	NMOD	0
18	day	day	I-NP	NN	O	19	SUB	0
19	decreased	decrease	B-VP	VBD	O	0	ROOT	18	decreased
20	serum	serum	B-NP	NN	O	21	NMOD	0
21	levels	level	I-NP	NNS	O	19	OBJ	0
22	of	of	B-PP	IN	O	21	NMOD	0
23	progesterone	progesterone	B-NP	NN	O	22	PMOD	0
24	,	,	O	,	O	19	P	0
25	as	as	B-SBAR	IN	O	19	VMOD	0
26	did	do	O	VBD	O	25	DEP	0
27	injection	injection	B-NP	NN	O	26	SUB	19	injection
28	of	of	B-PP	IN	O	27	NMOD	0
29	the	the	B-NP	DT	O	33	NMOD	0
30	selective	selective	I-NP	JJ	O	33	NMOD	0
31	COX-II	COX-II	I-NP	NN	O	33	NMOD	0
32	inhibitor	inhibitor	I-NP	NN	O	33	NMOD	0
33	NS-398	NS-398	I-NP	NN	O	28	PMOD	0
34	.	.	O	.	O	19	P	0

1	In	In	B-PP	IN	O	11	VMOD	0
2	contrast	contrast	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	11	P	0
4	a	a	B-NP	DT	O	7	NMOD	0
5	selective	selective	I-NP	JJ	O	7	NMOD	0
6	COX-I	COX-I	I-NP	NN	O	7	NMOD	0
7	inhibitor	inhibitor	I-NP	NN	O	9	NMOD	0
8	,	,	O	,	O	9	P	0
9	SC-560	SC-560	B-NP	NN	B-protein	11	SUB	0
10	,	,	O	,	O	9	P	0
11	had	have	B-VP	VBD	O	0	ROOT	0
12	no	no	B-NP	DT	O	13	NMOD	0
13	effect	effect	I-NP	NN	O	11	OBJ	16	effect
14	on	on	B-PP	IN	O	11	VMOD	0
15	serum	serum	B-NP	NN	O	17	NMOD	0
16	progesterone	progesterone	I-NP	NN	O	17	NMOD	0
17	concentrations	concentration	I-NP	NNS	O	14	PMOD	0
18	.	.	O	.	O	11	P	0

1	None	None	B-NP	NN	O	5	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	inhibitors	inhibitor	I-NP	NNS	O	2	PMOD	0
5	had	have	B-VP	VBD	O	0	ROOT	0
6	any	any	B-NP	DT	O	7	NMOD	0
7	effect	effect	I-NP	NN	O	5	OBJ	16	effect
8	on	on	B-PP	IN	O	5	VMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	weight	weight	I-NP	NN	O	8	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	the	the	B-NP	DT	O	14	NMOD	0
13	superovulated	superovulate	I-NP	VBN	O	14	NMOD	0
14	ovaries	ovary	I-NP	NNS	O	11	PMOD	0
15	or	or	B-PP	CC	O	8	PMOD	0
16	on	on	B-PP	IN	O	8	PMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	synthesis	synthesis	I-NP	NN	O	16	PMOD	8	synthesis
19	of	of	B-PP	IN	O	18	NMOD	0
20	progesterone	progesterone	B-NP	NN	O	19	PMOD	0
21	by	by	B-PP	IN	O	18	NMOD	0
22	cultured	culture	B-NP	VBN	B-cell_line	24	NMOD	0
23	luteal	luteal	I-NP	JJ	I-cell_line	24	NMOD	0
24	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	0
25	.	.	O	.	O	5	P	0

1	To	To	B-VP	TO	O	2	VMOD	0
2	determine	determine	I-VP	VB	O	17	VMOD	0
3	whether	whether	B-SBAR	IN	O	2	VMOD	0
4	changes	change	B-NP	NNS	O	7	SUB	16	changes
5	in	in	B-PP	IN	O	4	NMOD	0
6	angiogenesis	angiogenesis	B-NP	NN	O	5	PMOD	3	angiogenesis
7	are	be	B-VP	VBP	O	3	SBAR	0
8	responsible	responsible	B-ADJP	JJ	O	7	PRD	16	responsible
9	for	for	B-PP	IN	O	8	AMOD	0
10	the	the	B-NP	DT	O	11	NMOD	0
11	decrease	decrease	I-NP	NN	O	9	PMOD	18	decrease
12	in	in	B-PP	IN	O	11	NMOD	0
13	progesterone	progesterone	B-NP	NN	O	14	NMOD	0
14	synthesis	synthesis	I-NP	NN	O	12	PMOD	8	synthesis
15	,	,	O	,	O	17	P	0
16	we	we	B-NP	PRP	O	17	SUB	0
17	measured	measure	B-VP	VBD	O	0	ROOT	0
18	hemoglobin	hemoglobin	B-NP	NN	B-protein	21	NMOD	0
19	and	and	I-NP	CC	O	21	NMOD	0
20	CD34	CD34	I-NP	NN	B-protein	21	NMOD	0
21	levels	level	I-NP	NNS	O	17	OBJ	0
22	in	in	B-PP	IN	O	21	NMOD	0
23	luteinized	luteinize	B-NP	VBN	O	24	NMOD	2	luteinized
24	ovaries	ovary	I-NP	NNS	O	22	PMOD	0
25	following	follow	B-PP	VBG	O	21	NMOD	0
26	injection	injection	B-NP	NN	O	25	PMOD	0
27	of	of	B-PP	IN	O	26	NMOD	0
28	COX	COX	B-NP	NN	O	29	NMOD	0
29	inhibitors	inhibitor	I-NP	NNS	O	27	PMOD	0
30	and	and	O	CC	O	17	VMOD	0
31	measured	measure	B-VP	VBD	O	17	VMOD	0
32	the	the	B-NP	DT	O	34	NMOD	0
33	relative	relative	I-NP	JJ	O	34	NMOD	0
34	frequency	frequency	I-NP	NN	O	31	OBJ	0
35	of	of	B-PP	IN	O	34	NMOD	0
36	cells	cell	B-NP	NNS	O	35	PMOD	0
37	positive	positive	B-ADJP	JJ	O	36	NMOD	0
38	for	for	B-PP	IN	O	37	AMOD	0
39	platelet-endothelial	platelet-endothelial	B-NP	JJ	B-protein	42	NMOD	0
40	cell	cell	I-NP	NN	I-protein	42	NMOD	0
41	adhesion	adhesion	I-NP	NN	I-protein	42	NMOD	0
42	molecule	molecule	I-NP	NN	I-protein	38	PMOD	0
43	as	as	B-PP	IN	O	31	VMOD	0
44	a	a	B-NP	DT	O	46	NMOD	0
45	specific	specific	I-NP	JJ	O	46	NMOD	0
46	marker	marker	I-NP	NN	O	43	PMOD	0
47	for	for	B-PP	IN	O	46	NMOD	0
48	endothelial	endothelial	B-NP	JJ	B-cell_type	49	NMOD	0
49	cells	cell	I-NP	NNS	I-cell_type	47	PMOD	0
50	.	.	O	.	O	17	P	0

1	All	All	B-NP	DT	O	5	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	these	these	B-NP	DT	O	4	NMOD	0
4	parameters	parameter	I-NP	NNS	O	2	PMOD	0
5	were	be	B-VP	VBD	O	0	ROOT	0
6	reduced	reduce	I-VP	VBN	O	5	VC	0
7	by	by	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	10	NMOD	0
9	COX-II	COX-II	I-NP	NN	B-protein	10	NMOD	0
10	inhibitors	inhibitor	I-NP	NNS	I-protein	7	PMOD	0
11	,	,	O	,	O	5	P	0
12	suggesting	suggest	B-VP	VBG	O	5	VMOD	0
13	that	that	B-SBAR	IN	O	12	VMOD	0
14	changes	change	B-NP	NNS	O	18	SUB	16	changes
15	in	in	B-PP	IN	O	14	NMOD	0
16	the	the	B-NP	DT	O	17	NMOD	0
17	vasculature	vasculature	I-NP	NN	O	15	PMOD	0
18	are	be	B-VP	VBP	O	13	SBAR	0
19	responsible	responsible	B-ADJP	JJ	O	18	PRD	16	responsible
20	for	for	B-PP	IN	O	19	AMOD	0
21	the	the	B-NP	DT	O	22	NMOD	0
22	decrease	decrease	I-NP	NN	O	20	PMOD	18	decrease
23	in	in	B-PP	IN	O	22	NMOD	0
24	serum	serum	B-NP	NN	O	25	NMOD	0
25	progesterone	progesterone	I-NP	NN	O	23	PMOD	0
26	.	.	O	.	O	5	P	0

1	Histological	Histological	B-NP	JJ	O	2	NMOD	0
2	examination	examination	I-NP	NN	O	7	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	ovarian	ovarian	B-NP	JJ	O	6	NMOD	0
5	corrosion	corrosion	I-NP	NN	O	6	NMOD	0
6	casts	cast	I-NP	NNS	O	3	PMOD	0
7	indicated	indicate	B-VP	VBD	O	0	ROOT	0
8	that	that	B-SBAR	IN	O	7	VMOD	0
9	NS-398	NS-398	B-NP	NN	B-protein	10	SUB	0
10	inhibited	inhibit	B-VP	VBD	O	8	SBAR	18	inhibited
11	the	the	B-NP	DT	O	12	NMOD	0
12	establishment	establishment	I-NP	NN	O	10	OBJ	2	establishment
13	of	of	B-PP	IN	O	12	NMOD	0
14	luteal	luteal	B-NP	JJ	O	16	NMOD	0
15	capillary	capillary	I-NP	JJ	O	16	NMOD	0
16	vessels	vessel	I-NP	NNS	O	13	PMOD	0
17	following	follow	B-PP	VBG	O	10	VMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	injection	injection	I-NP	NN	O	17	PMOD	19	injection
20	of	of	B-PP	IN	O	19	NMOD	0
21	hCG	hCG	B-NP	NN	O	20	PMOD	0
22	.	.	O	.	O	7	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	are	be	B-VP	VBP	O	0	ROOT	0
4	consistent	consistent	B-ADJP	JJ	O	3	PRD	0
5	with	with	B-PP	IN	O	4	AMOD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	hypothesis	hypothesis	I-NP	NN	O	5	PMOD	0
8	that	that	B-SBAR	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	activity	activity	I-NP	NN	O	13	SUB	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	COX-II	COX-II	B-NP	NN	B-protein	11	PMOD	0
13	is	be	B-VP	VBZ	O	8	SBAR	0
14	associated	associate	I-VP	VBN	O	13	VC	16	associated
15	with	with	B-PP	IN	O	14	VMOD	0
16	the	the	B-NP	DT	O	17	NMOD	0
17	formation	formation	I-NP	NN	O	15	PMOD	2	formation
18	of	of	B-PP	IN	O	17	NMOD	0
19	functional	functional	B-NP	JJ	O	20	NMOD	0
20	CL	CL	I-NP	NN	O	18	PMOD	0
21	via	via	B-PP	IN	O	17	NMOD	0
22	its	its	B-NP	PRP$	O	23	NMOD	0
23	stimulation	stimulation	I-NP	NN	O	21	PMOD	17	stimulation
24	of	of	B-PP	IN	O	23	NMOD	0
25	angiogenesis	angiogenesis	B-NP	NN	O	24	PMOD	3	angiogenesis
26	.	.	O	.	O	3	P	0

